1/65
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
-Key elements of a good experimental design
Control (comparative), replication (Samples and experimental units per treatment), randomization (avoid bias)
-Sample size, experimental unit
Number of experimental units per treatment
-Organophosphates: History and uses
-man-made, many are now banned
-insecticides, herbicides, nerve gases, (solvents, plasticizers)
-Organophosphate Pesticides Example
-e.g., malathion(in use), parathion(banned), chlorpyrifos
-acute toxicity is high
-less persistent (days to weeks)
-Properties of Organophosphates:
-low log Kow (~3.0)
-will be taken up, but < organochlorines (DDT)
-does not biomagnify
-Persistence of Organophosphates:
-days to weeks
-hydrolysis, photolysis
-some break down into toxic compounds
-e.g., parathion ā paraoxon
-Toxicity of Organophosphates
-acutely toxic to mammals (only short exposure needed for problems)
-mode of action: inhibits the enzyme that breaks down acetylcholine (neurotransmitter)
-neurotoxin
-some are possible carcinogens
-Jose Casillas, age 15 (Organophosphate fatality)
-migrant worker in Utah orchard supporting family
-hit with āwaterā in field ā headache
-hit few days later with organophosphate from applicator ā ill
-next day biked to work, but collapsed and died
-Perfluoroalkyl substances history and uses (PFAS)
-invented in 1930s; commercial uses by 1950s, 3Mās Scotchguard
-Food packaging, makeup, stain-resistant furniture, Nonstick cookware, firefighting foam
-Forms/Structure of Perfluoroalkyl substances (PFAS)
-short C chains, lots of fluorine
-PFOA, PFOS
-Properties of Perfluoroalkyl substances (PFAS)
-moderate to high Kow
-bioaccumulate in tissue and blood
-act like PCBs, DDT, PBDEs, but accumulate through different pathways
-1/2 of 4 years in body
-shorter chains leave faster
-Persistence of Perfluoroalkyl substances (PFAS)
-Decades (known as āforever chemicalsā)
-Can now be found in all matrices, around the globe
-Still in use, so will continue to increase
-EPA working on remediation strategies
-Landfill? Incinerator? Recycling?
-Toxicity of Perfluoroalkyl substances (PFAS) including the body
-Go to blood, liver, kidney
-Cancer, affects kidney, liver, endocrine system
(thyroid, pancreas, increased cholesterol), immune system (autoimmune issues),
-No official criteria or limits yet (propose 4 ppt)
-Tentative limit of 12 ppt in some states
-Problems with removing PFAS
-New proposed Federal standards: 4 ppt (parts-per-trillion) for PFOA and PFOS
-Very expensive to remove PFAS. Need to update utilitiesā technologies (e.g., activated carbon filters)
-May not be able to meet this standard of 4 ppt and activated carbon filters
-Too many PFAS to collect toxicity and persistence of each to get a good answer for removing the most PFAS
-Primary (physical)
-Remove large solids with grates, screens, settling tanks
-secondary (bacteria and other microbes to break down organic matter ā aerated)
-trickling filter
-rotating biological contactors
-activated sludge
-tertiary treatments (as needed; not all plants)
-remove additional suspended solids, nutrients, toxic materials
-reverse osmosis (lead, VOCs, PFAS), Alum (coagulant for SS, settler), wetlands (nutrients)
-disinfection
-Cl contact basins, O3, UV, sometimes omitted during the winter
-sludge treatments (digestion)
-Reduce organic matter, odor, water content
-May be landfilled, used as fertilizer
-generates methane CH4
-Processes involved in partitioning: Volatilization
transport of a chemical from the aqueous phase (water) to the gas phase (atmosphere)
-Processes involved in partitioning: Atmospheric deposition
ā transport of chemical from atm to surface
-wet- rain, snow, fog
-dry- gases, aerosols, particulates
-Processes involved in partitioning: Adsorption
-chemical attaches to a surface
(sorption/desorption)
-Processes involved in partitioning: Sedimentation
-deposition of suspended solids onto bottom of water body
-Processes involved in partitioning: Precipitation
-formation of a solid phase
when chemical exceeds solubility
-Bioaccumulation
-net uptake of chemical from the environment by all sourcesā respiration, diet, water, dermal
-Bioconcentration
-net uptake of a chemical from water alone
-Biomagnification
-large (orders of magnitude) increase in contaminant concentration from one trophic level to the next through accumulation in food
-Biomagnification factors
-Properties of the chemical (e.g., lipophilic)
-Higher trophic level organisms are generally: longer-lived, larger, have more lipid
-Lower trophic level organisms tend to grow faster: more growth dilution, shorter lived
Ā -Uptake at the cellular levelĀ (lipid route)
-Lipophilic uptake
-Diffusion of lipophilic contaminants across membrane lipid bilayer (Benzene)
-High Kow values
-Uptake at the cellular levelĀ (aqueous route)
-contaminants enter through diffusion, facilitated diffusion, active transport
-Facilitated diffusion: diffused with a carrier protein, better for larger molecules (metals)
-Active transport: goes against [ ] gradient Cd instead of Ca
-Facilitated diffusion: (aq-route;non-lipid)
diffused with a carrier protein, better for larger molecules (metals)
-Active transport: (aq-route;non-lipid)
goes against [ ] gradient Cd instead of Ca
-Cellular uptake Kow trends
-the higher its Kow, the higher its solubility in lipidsā the higher the importance of the lipid route of uptake
-Elimination routes
Bile, Urine, Feces, Feathers, Molting (in reptiles, insects) , Exhalation (for volatile compounds), Eggs and milk (especially for lipophilic toxicants like PBDEs or DDT)
-Rate constant model of elimination, BAF
-Bioaccumulation Factor (BAF) = [organism] / [Sediment/Food]
-Rate constant model of elimination, BCF
-Bioconcentration Factor (BCF) = [organism] / [water] (ONLY H2O)
-Factors affecting bioavailability and bioaccumulation (chemical, environmental, organismal)
-Chemical structure
-Form (e.g., organic vs. ionic form of metals)
-Log Kow (low values below 6)
-Factors affecting bioavailability and bioaccumulation: environmental
-T, aerobic/anaerobic, hardness, alkalinity, pH
-Factors affecting bioavailability and bioaccumulation: Organismal
-Exposure route, lipid content, age, size, sex, behavior (avoidance IRL)
-Biotransformation of organics (Phase I)
-Oxidation, reduction, or hydrolysis reactions
-Catalyzed by P450 enzymes
-Functional group added (trailer hitch)
-Makes some chemicals hydrophilic enough to be excretable (although sometimes more toxic or carcinogenic)
-Other chemicals still too lipophilic...
-Biotransformation of organics (Phase 2)
-Conjugation reactions (hook up to trailer hitch)
-Adds water-soluble molecules to the contaminant.
ā Amino acids
ā Sulfates
ā Glucuronic acid
-Catalyzed by Transferases (not CYT P450 enzymes)
-Cytochrome P450 enzymes (CYPs) (phase 1)
-Light-absorbing pigments
-Located in cell membranes (e.g., liver, gills)
-Some species have multiple types
-Transferase enzymes (phase 2)
-found in the cytoplasm
Overall goal of Biotransformation
to make contaminants more hydrophilic for easier elimination
-Sublethal effects
-growth, development, reproduction, behavior, stress biomarkers, immune response, genetic diversity
-KEY: Diminish fitness
-Endocrine System
-A chemical-based communication system that allows integrated control of cell metabolism, division, and growth.
-Endocrine systems are similar among species. EDCs can act similar among species
-Endocrine disruption (EDC)
-Any natural or synthetic agent that interferes with the synthesis, transport, binding, action or elimination of natural hormones in the endocrine system
-endocrine disruptor examples
-Herbicides, fungicides, insecticides, Cd, Pb, Phytoesrtogens
-modes of action (EDCs)
-Agonists: mimic or partly mimic hormones
-Antagonists: prevent or alter hormonal binding to hormone receptors
-Agonists
mimic or partly mimic hormones
-Antagonists:
prevent or alter hormonal binding to hormone receptors
-modes of action (EDCs)
-May alter transport of hormones
may bind to transport proteins
-modes of action (EDCs)
-May alter breakdown of hormones
may inhibit certain enzymes
-Classic Examples of EDCs in the Environment
Lake Apopka alligators
Ā Ā Ā Ā Ā -DDE dumped here in 1980
Ā Ā Ā Ā Ā -small penises ā pop decline
Ā Ā Ā Ā Ā -susceptible to disease
-Classic Examples of EDCs in the Environment
Tyrone Hayes vs. Syngenta
Deformities and intersex in frogs
atrazine as low as 1 ppb caused ovotestes
-EDC: Cadmium
Sources/Uses: Cd
byproduct of mining/smelting zinc, lead, and copper, and of burning fossil fuels, tobacco
pigments, metal-plating, batteries, plastics
Cd in the endocrine system
- binds to estrogen and androgen receptors
-reduces progesterone (ovulation, pregnancy)
-causes testicular hemorrhage w/edema
Needs for toxicity data
For use in regulating inputs
establish surface water quality criteria
establish drinking water standards application limits or rates
Risk Assessment
Acute Testing
-higher concentrations
-shorter exposure duration
-duration depends on species
-endpoint: mortality or immobilization
-animals not fed
ChronicĀ Testing
-lower (mostly sublethal) concentrations
-based on acute testing
-longer exposure duration
-endpoints: growth, reproduction, etc.
-animals fed
Data collection Toxicity tests
Acute: mortality (daily)
Chronic: mortality (daily)
sublethal endpoints (daily: reproduction)
sublethal endpoints (at end: growth)
All: water quality parameters (daily)
Transformation: Hydrolysis
Chemical reaction with water
Transformation: Photolysis
Breakdown by sunlight
Rate constant model of elimination: Single Compartment Model
Model Assumes uniform concentration in the body
Formula: dC/dt = -kC
Rate constant model of elimination: Multi Compartment Model
āFastā and āslowā compartments
Fast: e.g., blood or soft tissue
Slow: e.g., fat or bone
Rate constant model of elimination: PBPK Model
Physiologically Based Pharmacokinetic Models
More realisticāmodels specific organs (gills, liver, muscle, etc.)
Requires dissection and measurement of compartments